Gilead Sciences (Nasdaq:GILD) announced that it broke ground on its new pharmaceutical development and manufacturing (PDM) technical development center (NTDC) in California. The facility, located at the company’s Foster City headquarters, comes as part of a $32 billion investment in U.S. innovation through 2030. Gilead expects the investment to generate more than $43 billion in… The post Gilead breaks ground on California manufacturing hub appeared first on Pharmaceutical Processing World.| Pharmaceutical Processing World
Gilead Sciences is building an AI-enabled lab in Foster City, California, as the first part of a $32bn investment scheme that includes a number of a new high-tech Industry 4.0 constructions. Due to open in 2026, the site will drive oncology and inflammation research while boosting US biopharma growth. In sum – what to know: […]| RCR Wireless News
The new drug lenacapavir, which gives almost complete protection against the H.I.V. virus, was to be administered across Africa this year. Now, much of the| Erasing 76 Crimes